indoline has been researched along with Infections, Plasmodium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eggimann, FK; Einolf, HJ; Favara, S; Forseth, RR; Gu, H; He, H; Huskey, SE; Kittelmann, M; Li, H; Lin, MM; Luneau, A; Mangold, JB; Simon, O; Vargas, A; Wang, L; Zhang, J; Zhu, CQ | 1 |
| Fredenhagen, A; Huskey, SE; Jain, JP; Jian, Z; Kühnöl, J; Luneau, A; Mangold, JB; Miao, Z; Stein, DS; Sunkara, G; Yang, F; Yang, Z; Zhu, CQ | 1 |
2 other study(ies) available for indoline and Infections, Plasmodium
| Article | Year |
|---|---|
Identification of Three Novel Ring Expansion Metabolites of KAE609, a New Spiroindolone Agent for the Treatment of Malaria, in Rats, Dogs, and Humans.
Topics: Animals; Bile; Biotransformation; Cytochrome P-450 Enzyme System; Dogs; Feces; Hepatocytes; Humans; Hydroxylation; Indoles; Malaria; Male; Rats; Rats, Wistar; Spiro Compounds | 2016 |
KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male Subjects.
Topics: Administration, Oral; Adult; Body Fluids; Carbon Radioisotopes; Feces; Healthy Volunteers; Humans; Hydroxylation; Indoles; Malaria; Male; Metabolic Networks and Pathways; Middle Aged; Oxidation-Reduction; Spiro Compounds | 2016 |